Workflow
Anktiva drug
icon
Search documents
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Businesswire· 2026-03-29 04:13
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm Mar 29, 2026 12:13 AM Eastern Daylight Time IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm Share This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. Contacts The Schall Law Firm Brian Schall, Esq., www.schallfirm.comOffice: 310-301-3335 info@schallfirm.com LOS ANGELES- ...